Controlling the kinetics of interferon transgene expression for improved gene therapy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of drug targeting (Print)

• Publication date

  2012-10-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/1061186X.2012.716848PMID 22994266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• © The American Society of Gene & Cell Therapy original article The Extragenic Spacer Length Between the 5 ′ and 3 ′ Ends of the Transgene Expression Cassette Affects Transgene Silencing From Plasmid-based Vectors

  2012cited by this paper
• Constant and steady transgene expression of interferon‐γ by optimization of plasmid construct for safe and effective interferon‐γ gene therapy

  2012cited by this paper
• Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies

  2012cited by this paper
• Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector.

  2012cited by this paper
• Advances in Gene Delivery Systems

  2011cited by this paper
• Sustained, high transgene expression in liver with plasmid vectors using optimized promoter‐enhancer combinations

  2011cited by this paper
• State-of-the-art gene-based therapies: the road ahead

  2011cited by this paper
• Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver

  2011cited by this paper
• Minicircle-oriP-IFNγ: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma

  2011influential reference
• Redefining the role of interferon in the treatment of malignant diseases.

  2010cited by this paper
• Gene Transfer: How Can the Biological Barriers Be Overcome?

  2010cited by this paper
• Sustained Exogenous Expression of Therapeutic Levels of IFN-γ Ameliorates Atopic Dermatitis in NC/Nga Mice via Th1 Polarization

  2010cited by this paper
• Liposomes for Use in Gene Delivery

  2010cited by this paper
• Nonviral Gene Delivery: Principle, Limitations, and Recent Progress

  2009cited by this paper
• Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins.

  2009cited by this paper
• Use of minicircle plasmids for gene therapy.

  2009cited by this paper
• Transfection by particle bombardment: delivery of plasmid DNA into mammalian cells using gene gun.

  2009cited by this paper
• Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction

  2009cited by this paper
• Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression

  2009cited by this paper
• Regulated expression of the interferon-β gene in mice

  2008influential reference
• Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.

  2008cited by this paper
• A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.

  2008cited by this paper
• Computer-assisted hydrodynamic gene delivery.

  2008cited by this paper
• A phase I clinical trial of interferon‐beta gene therapy for high‐grade glioma: novel findings from gene expression profiling and autopsy

  2008cited by this paper
• Regulated expression of the interferon-beta gene in mice.

  2008influential reference
• Interferon-inducible antiviral effectors

  2008cited by this paper
• Reactivation of Silenced Transgene Expression in Mouse Liver by Rapid, Large-Volume Injection of Isotonic Solution

  2008cited by this paper
• Improved anti‐cancer effect of interferon gene transfer by sustained expression using CpG‐reduced plasmid DNA

  2007cited by this paper
• Development and validation of a robust and versatile one-plasmid regulated gene expression system.

  2007cited by this paper
• Non-viral is superior to viral gene delivery.

  2007cited by this paper
• Gene therapy clinical trials worldwide to 2007—an update

  2007influential reference
• Minicircle-IFNγ Induces Antiproliferative and Antitumoral Effects in Human Nasopharyngeal Carcinoma

  2006influential reference
• Plasmid Engineering for Controlled and Sustained Gene Expression for Nonviral Gene Therapy

  2006cited by this paper
• Physical methods for gene transfer: improving the kinetics of gene delivery into cells.

  2005cited by this paper
• Investigations of the effect of DNA size in transient transfection assay using dual luciferase system.

  2005cited by this paper
• Controlling the kinetics of transgene expression by plasmid design.

  2005cited by this paper
• DNA-based therapeutics and DNA delivery systems: A comprehensive review

  2005cited by this paper
• Increased Maintenance and Persistence of Transgenes by Excision of Expression Cassettes from Plasmid Sequences In Vivo

  2005cited by this paper
• Mechanisms of type-I- and type-II-interferon-mediated signalling

  2005cited by this paper
• Design and development of polymers for gene delivery

  2005cited by this paper
• Hydroporation as the mechanism of hydrodynamic delivery

  2004cited by this paper
• Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo

  2004influential reference
• Gene therapy clinical trials worldwide 1989–2004—an overview

  2004influential reference
• Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy

  2004cited by this paper
• Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo.

  2003cited by this paper
• The antiprogestin-dependent GeneSwitch system for regulated gene therapy.

  2003cited by this paper
• Development of Catheter-Based Procedures for Transducing the Isolated Rabbit Liver with Plasmid DNA

  2002cited by this paper
• Nonviral approaches satisfying various requirements for effective in vivo gene therapy.

  2002cited by this paper
• CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo.

  2002cited by this paper
• Epstein-Barr virus in the pathogenesis of NPC.

  2002cited by this paper
• Nonviral Vectors in the New Millennium: Delivery Barriers in Gene Transfer

  2001cited by this paper
• The Minimal Replicator of Epstein-Barr VirusoriP

  2000cited by this paper
• The role of CpG motifs in immunostimulation and gene therapy.

  2000cited by this paper
• Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency.

  1999cited by this paper
• Direct Cutaneous Gene Delivery in a Human Genetic Skin Disease

  1997cited by this paper
• Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer.

  1997cited by this paper
• Direct gene transfer into mouse muscle in vivo.

  1990cited by this paper

• The chronODE framework for modelling multi-omic time series with ordinary differential equations and machine learning

  2025cites this paper
• Therapeutic implications of the interplay between interferons and ER in breast cancer.

  2024cites this paper
• chronODE: A framework to integrate time-series multi-omics data based on ordinary differential equations combined with machine learning

  2023cites this paper
• Gene-Activated Materials in Regenerative Dentistry: Narrative Review of Technology and Study Results

  2023cites this paper
• The Effect of Repeat Administration of Lipoplexes on Gene Delivery, Biodistribution, and Cytokine Response in Immunocompetent Tumor-bearing Mice.

  2021cites this paper
• The Use of Lactose as an Alternative Coating for Nanoparticles.

  2020cites this paper
• A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol.

  2019cites this paper
• Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery

  2018cites this paper
• Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.

  2017cites this paper
• Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery

  2016cites this paper
• Effect of charge ratio on lipoplex-mediated gene delivery and liver toxicity.

  2015cites this paper
• Relating Toxicity to Transfection: Using Sphingosine To Maintain Prolonged Expression in Vitro

  2014cites this paper
• A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity

  2013cites this paper